(Q59563317)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21458316%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

title

Prostate-specific antigen (PSA) should drive doing prostate biopsies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21458316%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21458316%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

author name string

William J Catalona

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21458316%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

publication date

1 April 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21458316%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21458316%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21458316%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21458316%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

page(s)

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21458316%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

cites work

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.10.007

PSA screening among elderly men with limited life expectancies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.10.007

Mortality results from the Göteborg randomised population-based prostate-cancer screening trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.10.007

Mortality results from a randomized prostate-cancer screening trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.10.007

Prostate biopsy following a positive screen in the prostate, lung, colorectal and ovarian cancer screening trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.10.007

Screening and prostate-cancer mortality in a randomized European study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.10.007

Prostate cancer mortality in screen and clinically detected prostate cancer: estimating the screening benefit.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.10.007

What would you do, doctor?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.10.007

Can prostate specific antigen velocity thresholds decrease insignificant prostate cancer detection?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.10.007

Detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.10.007

Prostate-specific antigen (PSA) isoform p2PSA in combination with total PSA and free PSA improves diagnostic accuracy in prostate cancer detection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.10.007

10.1016/J.UROLONC.2010.10.007

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21458316%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference